150 related articles for article (PubMed ID: 5292990)
1. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.
Alford FP; Larkins RG; Martin FI
Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990
[No Abstract] [Full Text] [Related]
2. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
3. [Clinical studies of long-acting thyroid stimulator].
Eguchi Y
Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):939-52. PubMed ID: 4099204
[No Abstract] [Full Text] [Related]
4. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
5. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
[No Abstract] [Full Text] [Related]
6. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
[No Abstract] [Full Text] [Related]
7. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Gautier E; Juillard E; Lemarchand-Béraud T
Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
[No Abstract] [Full Text] [Related]
8. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
McKenzie JM; McCullagh EP
J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
[No Abstract] [Full Text] [Related]
9. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
10. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
11. The nucleic acid content of lymphocytes in thyrotoxicosis.
Smith JF; Glen AC; Greig WR
Clin Exp Immunol; 1971 Jun; 8(6):911-6. PubMed ID: 5104635
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of thyrotoxicosis the discovery of LATS.
Adams DD
N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
[No Abstract] [Full Text] [Related]
13. [The long-acting thyroid stimulator (LATS) in untreated and I-131 treated hyperthyreoses, following total thyroidectomy, as well as its relation to thyroid antibodies].
Ziemke A; Weisbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W
Klin Wochenschr; 1968 Oct; 46(19):1025-7. PubMed ID: 5727481
[No Abstract] [Full Text] [Related]
14. Changes in LATS and other thyoid autoantibody levels with therapy.
Kilpatrick JA
N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
[No Abstract] [Full Text] [Related]
15. Treatment of thyrotoxicosis--the current position. I. Classification, causation and treatment.
Greig WR
Curr Med Res Opin; 1972; 1(3):144-52. PubMed ID: 4589708
[No Abstract] [Full Text] [Related]
16. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
Emrich D; Albani M; zur Mühlen A von
Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
[No Abstract] [Full Text] [Related]
17. Metastatic thyroid carcinoma provoking hyperthyroidism, with elevated circulating thyrostimulators.
Valenta L; Lemarchand-Béraud T; Nĕmec J; Griessen M; Bednár J
Am J Med; 1970 Jan; 48(1):72-6. PubMed ID: 4190112
[No Abstract] [Full Text] [Related]
18. Thyroid function in patients treated with radioactive iodine for thyrotoxicosis.
Tunbridge WM; Harsoulis P; Goolden AW
Br Med J; 1974 Jul; 3(5923):89-92. PubMed ID: 4855207
[TBL] [Abstract][Full Text] [Related]
19. [Biological investigation in hyperthyroidism].
Guinet P
Cah Med; 1972 Dec; 13(17):1235-42. PubMed ID: 4121374
[No Abstract] [Full Text] [Related]
20. Hyperthyroidism and excessive thyrotropin secretion.
Emerson CH; Utiger RD
N Engl J Med; 1972 Aug; 287(7):328-33. PubMed ID: 4114408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
